Evidence map›Paper›PMID 41909692›Full record

ArticleFrontiers in immunology2026

Amplification cycles through innate lymphoid cells at the onset of lupus nephritis.

Rosa L Kreider, Stylianos-Iason Biniaris-Georgallis, Bastian Grothey, Antigoni Triantafyllopoulou, Lisa M Steinheuer, Kevin Thurley

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rosa L Kreider *Biomathematics Division, Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.
Stylianos-Iason Biniaris-Georgallis *Department of Nephrology and Medical Intensive Care, Charite-Universitätsmedizin Berlin, Berlin, Germany.
Bastian GrotheyBiomathematics Division, Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.
Antigoni TriantafyllopoulouDepartment of Nephrology and Medical Intensive Care, Charite-Universitätsmedizin Berlin, Berlin, Germany.
Lisa M SteinheuerBiomathematics Division, Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.
Kevin ThurleyBiomathematics Division, Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease progression in autoimmune conditions such as systemic lupus erythematosus (SLE) is highly heterogeneous, and the cellular and molecular mechanisms driving disease-onset dynamics remain incompletely understood. Here, based on single-cell transcriptomics data on lupus-prone NZB/W F1 mice, we derived a mathematical cell-cell interaction model recapitulating early dynamics of innate immune cells in lupus nephritis. We identified a diverse landscape of tissue-associated ILC and vessel-associated NK cell populations. We conceived a scalable mathematical framework for analysis of immune-cell interaction dynamics. A specific model formulation considers ILC as amplifiers of inflammatory processes in the presence of autoantibodies in lupus-prone individuals. Systematic model analyses highlight the impact of positive feedback loops and spontaneous inflammatory events or environmental stimuli, and the timing-dependent effectiveness of depletion therapies. Additionally, our model links the critical role of ILC populations to hallmarks of SLE such as highly heterogeneous disease dynamics. Overall, our findings lay the groundwork towards a mathematical model of immune-tissue cellular crosstalk, enabling quantification of disease severity and prediction of responses to biologic treatments in autoimmune diseases.

Indexed as

Immunity, InnateLupus NephritisLymphocytesAnimalsAutoantibodiesCell CommunicationDisease Models, AnimalFemaleHumansKiller Cells, NaturalMiceMice, Inbred NZBSingle-Cell AnalysisAutoantibodiesautoantibodiesautoimmune diseasecell-cell communicationmathematical modelNZB/W F1 miceresponse-time modelingsingle-cell transcriptomics

Identifiers

PMID41909692
PMCPMC13018116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.